NCT07036562 Time-restricted Eating and High-intensity Interval Training for Metabolic Health in Adults With Overweight/Obesity
| NCT ID | NCT07036562 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Norwegian University of Science and Technology |
| Condition | Overweight and Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-09-11 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-09-11 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will investigate the effects of 12 months periodised time-restricted eating combined with high-intensity interval training compared with a control group on fat mass in adults with overweight/obesity. Participants in the intervention group will complete the intervention remotely and will receive follow-up by telephone. Before randomisation, after 6 months and after 12 months, the investigators will measure the participants' body composition, physical fitness, fasting blood glucose and insulin, blood lipids, and blood pressure. Physical activity, diet, sleep quality, appetite, and adherence to the intervention will also be measured. Secondary sub-analyses of sex differences in the responses to the intervention will be performed.
Eligibility Criteria
Inclusion Criteria: * Body mass index ≥ 27 kg/m² * Able to walk or ride a bike \> 60 min Exclusion Criteria: * On-going pregnancy * Lactation within 24 weeks of study commencement * High-intensity exercise ≥ 1/week * Habitual eating window ≤12 hours/day * Taking hypertension, glucose-, or lipid-lowering drugs * Body mass variation ≥ 4 kg three months prior to study commencement * Known diabetes mellitus (type 1 or 2) or cardiovascular disease * Working night shifts
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07036562 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Overweight and Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07036562 currently recruiting?
Yes, NCT07036562 is actively recruiting participants. Contact the research team at kamilla.l.haganes@ntnu.no for enrollment information.
Where is the NCT07036562 trial being conducted?
This trial is being conducted at Trondheim, Norway.
Who is sponsoring the NCT07036562 clinical trial?
NCT07036562 is sponsored by Norwegian University of Science and Technology. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.